Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Pernix Therapeutics Holdings Inc (NASDAQ:PTX)

4.01
Delayed Data
As of May 26
 -0.29 / -6.74%
Today’s Change
1.83
Today|||52-Week Range
10.40
+106.70%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Revenue and IncomeNet Revenues36.7M41.5M30.2M29.7M
 
 
 
 
 
Cost of Goods Sold12.2M10.8M9.0M10.0M
 
 
 
 
 
Depreciation And Amortization21.1M20.7M20.7M18.6M
 
 
 
 
 
 
Operating ExpensesGross Income3.5M9.9M413.0K1.2M
 
 
 
 
 
General Expenses28.0M23.9M26.2M20.8M
 
 
 
 
 
Research And Development2.5M1.7M940.0K528.0K
 
 
 
 
 
Total Operating Expenses61.2M55.4M55.9M49.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-24.5M-14.0M-25.7M-19.6M
 
 
 
 
 
Extraordinary Credit4.1M0.004.9M0.00
 
 
 
Extraordinary Charge0.00-3.0M-30.0M-800.0K
 
 
 
 
Interest Expense On Debt8.9M8.9M11.0M9.0M
 
 
 
 
 
Other Expenses-1.8M-621.0K-23.8M0.00
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-31.1M-26.4M-85.7M-29.4M
 
 
 
 
 
Income Taxes-10.0K-1.0K-413.0K-55.0K
 
 
 
 
 
Net Income-31.1M-26.4M-86.1M-29.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS6.7M8.8M10.0M10.0M
 
 
 
 
 
Shares To Calculate EPS Diluted6.7M8.8M10.0M10.0M
 
 
 
 
 
 
Earnings Per ShareEPS-$4.70-$29.90-$8.92-$2.94
 
 
 
 
 
EPS Diluted-$4.70-$2.99-$8.59-$2.94